Experimental Alzheimer’s drug slows cognitive decline in trial

WELLINGTON: An experimental Alzheimer’s drug slowed cognitive and functional decline by 27 percent in a…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In